{"id":"NCT00325130","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)","officialTitle":"An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of V501 Given Concomitantly With Menactra™ and ADACEL™ in Healthy Adolescents 11-17 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2007-04","completion":"2007-04","firstPosted":"2006-05-12","resultsPosted":"2009-07-13","lastUpdate":"2015-03-12"},"enrollment":1042,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Neoplasms, Glandular and Epithelial","Diphtheria","Tetanus","Whooping Cough","Meningitis"],"interventions":[{"type":"BIOLOGICAL","name":"Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine","otherNames":["Gardasil"]},{"type":"BIOLOGICAL","name":"Comparator: Menactra™ (Concomitant)","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Adacel™ (Concomitant)","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Menactra™ (Non-concomitant)","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Adacel™","otherNames":[]}],"arms":[{"label":"Group 1","type":"EXPERIMENTAL"},{"label":"Group 2","type":"EXPERIMENTAL"}],"summary":"Data from this study are expected to demonstrate that V501 (Human Papillomavirus (HPV) \\[Types 6, 11, 16, 18\\] Recombinant Vaccine) , when administered concomitantly with a combined diphtheria, tetanus, pertussis (Tdap) vaccine and a meningococcal conjugate vaccine in adolescents remains immunogenic and well-tolerated and it does not impair the immunogenicity of the concomitant vaccines.","primaryOutcome":{"measure":"Number of Subjects Who Seroconverted for Human Papillomavirus (HPV) Type 6 (HPV 6 ≥ 20 mMU/mL) by Week 4 Postdose 3 (7 Months)","timeFrame":"7 Months","effectByArm":[{"arm":"Concomitant Administration","deltaMin":416,"sd":null},{"arm":"Non-concomitant Administration","deltaMin":417,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20439595"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Injection Site Pain ADACEL™ + Menactra™","Injection Site Pain quadrivalent HPV Vaccine postvaccination 1","Injection Site Pain qHPV Vaccine (postvaccination 3)","Injection Site Pain qHPV Vaccine (postvaccination 2)","Injection Site Swelling ADACEL™ + Menactra™"]}}